NCT06462118 - A Study to Evaluate the Effect of Injection Site on PK of Astegolimab in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 17, 2024

Primary Completion Date

October 22, 2024

Study Completion Date

October 22, 2024

Conditions

Healthy Volunteers

Interventions

DRUG

Astegolimab

Participants will receive one SC dose of astegolimab in the abdomen, upper arm, or thigh.

Trial Locations (3)

Covance Research Unit - Daytona, Daytona Beach

Covance Clinical Research Unit, Inc, Madison

Covance Research Unit - Dallas, Dallas